138 related articles for article (PubMed ID: 33045355)
1. Immunomodulatory effects of colistin on host responses against carbapenem-resistant Klebsiella pneumoniae biofilms.
Geladari A; Simitsopoulou M; Antachopoulos C; Roilides E
Int J Antimicrob Agents; 2020 Dec; 56(6):106182. PubMed ID: 33045355
[TBL] [Abstract][Full Text] [Related]
2. Dose-Dependent Synergistic Interactions of Colistin with Rifampin, Meropenem, and Tigecycline against Carbapenem-Resistant Klebsiella pneumoniae Biofilms.
Geladari A; Simitsopoulou M; Antachopoulos C; Roilides E
Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30642942
[TBL] [Abstract][Full Text] [Related]
3. Daptomycin exerts differential immunomodulatory effects on host responses against methicillin-resistant Staphylococcus aureus biofilms.
Simitsopoulou M; Kadiltzoglou P; Antachopoulos C; Roilides E
Int J Antimicrob Agents; 2022 Oct; 60(4):106666. PubMed ID: 36038095
[TBL] [Abstract][Full Text] [Related]
4. In vitro evaluation of different antimicrobial combinations against carbapenemase-producing Klebsiella pneumoniae: the activity of the double-carbapenem regimen is related to meropenem MIC value.
Oliva A; Scorzolini L; Cipolla A; Mascellino MT; Cancelli F; Castaldi D; D'Abramo A; D'Agostino C; Russo G; Ciardi MR; Mastroianni CM; Vullo V
J Antimicrob Chemother; 2017 Jul; 72(7):1981-1984. PubMed ID: 28369424
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Sensititre Broth Microdilution Plate for determining the susceptibility of carbapenem-resistant Klebsiella pneumoniae to polymyxins.
Richter SS; Karichu J; Otiso J; Van Heule H; Keller G; Cober E; Rojas LJ; Hujer AM; Hujer KM; Marshall S; Perez F; Rudin SD; Domitrovic TN; Kaye KS; Salata R; van Duin D; Bonomo RA
Diagn Microbiol Infect Dis; 2018 May; 91(1):89-92. PubMed ID: 29456071
[TBL] [Abstract][Full Text] [Related]
6. Serum Antibody Responses against Carbapenem-Resistant Klebsiella pneumoniae in Infected Patients.
Banerjee K; Motley MP; Diago-Navarro E; Fries BC
mSphere; 2021 Mar; 6(2):. PubMed ID: 33658281
[TBL] [Abstract][Full Text] [Related]
7. Inactivation of mgrB gene regulator and resistance to colistin is becoming endemic in carbapenem-resistant Klebsiella pneumoniae in Greece: A nationwide study from 2014 to 2017.
Hamel M; Chatzipanagiotou S; Hadjadj L; Petinaki E; Papagianni S; Charalampaki N; Tsiplakou S; Papaioannou V; Skarmoutsou N; Spiliopoulou I; Christofidou M; Papamichalopoulos N; Skalidis T; Legakis N; Fountoulis K; Perivolioti E; Kraniotaki H; Bournia M; Ioannidis A; Baron Sophie A; Rolain JM
Int J Antimicrob Agents; 2020 Apr; 55(4):105930. PubMed ID: 32130981
[TBL] [Abstract][Full Text] [Related]
8. The Role of IgG Subclass in Antibody-Mediated Protection against Carbapenem-Resistant Klebsiella pneumoniae.
Motley MP; Diago-Navarro E; Banerjee K; Inzerillo S; Fries BC
mBio; 2020 Sep; 11(5):. PubMed ID: 32900809
[TBL] [Abstract][Full Text] [Related]
9. Colistin resistance in carbapenemase-producing Klebsiella pneumoniae bloodstream isolates: Evolution over 15 years and temporal association with colistin use by time series analysis.
Tansarli GS; Papaparaskevas J; Balaska M; Samarkos M; Pantazatou A; Markogiannakis A; Mantzourani M; Polonyfi K; Daikos GL
Int J Antimicrob Agents; 2018 Sep; 52(3):397-403. PubMed ID: 29960007
[TBL] [Abstract][Full Text] [Related]
10. [Aminoglycosides and colistin inhibit biofilm formation in Klebsiella pneumoniae].
Hostacká A; Ciznár I
Epidemiol Mikrobiol Imunol; 2008 Aug; 57(3):101-5. PubMed ID: 18767377
[TBL] [Abstract][Full Text] [Related]
11. Weak biofilm formation among carbapenem-resistant Klebsiella pneumoniae.
Cusumano JA; Caffrey AR; Daffinee KE; Luther MK; Lopes V; LaPlante KL
Diagn Microbiol Infect Dis; 2019 Dec; 95(4):114877. PubMed ID: 31484626
[TBL] [Abstract][Full Text] [Related]
12. Comparison of synergism between colistin, fosfomycin and tigecycline against extended-spectrum β-lactamase-producing Klebsiella pneumoniae isolates or with carbapenem resistance.
Ku YH; Chen CC; Lee MF; Chuang YC; Tang HJ; Yu WL
J Microbiol Immunol Infect; 2017 Dec; 50(6):931-939. PubMed ID: 28716360
[TBL] [Abstract][Full Text] [Related]
13. Heteroresistance to colistin in Klebsiella pneumoniae is triggered by small colony variants sub-populations within biofilms.
Silva A; Sousa AM; Alves D; Lourenço A; Pereira MO
Pathog Dis; 2016 Jul; 74(5):. PubMed ID: 27140200
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of ComASP™ Colistin (formerly SensiTest™ Colistin), a commercial broth microdilution-based method to evaluate the colistin minimum inhibitory concentration for carbapenem-resistant Klebsiella pneumoniae isolates.
Galani I; Adamou P; Karaiskos I; Giamarellou H; Souli M
J Glob Antimicrob Resist; 2018 Dec; 15():123-126. PubMed ID: 30036693
[TBL] [Abstract][Full Text] [Related]
15. Correlation between antimicrobial consumption and the prevalence of carbapenem-resistant Escherichia coli and carbapenem-resistant Klebsiella pneumoniae at a university hospital in Thailand.
Prakobsrikul N; Malathum K; Santanirand P; Chumnumwat S; Piebpien P; Montakantikul P
J Clin Pharm Ther; 2019 Apr; 44(2):292-299. PubMed ID: 30578578
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology and molecular characterisation of colistin-resistant Klebsiella pneumoniae isolates from immunocompromised patients in Tunisia.
Tanfous FB; Raddaoui A; Chebbi Y; Achour W
Int J Antimicrob Agents; 2018 Dec; 52(6):861-865. PubMed ID: 30176353
[TBL] [Abstract][Full Text] [Related]
17. ASK2 Bioactive Compound Inhibits MDR
Lalitha C; Raman T; Rathore SS; Ramar M; Munusamy A; Ramakrishnan J
Front Cell Infect Microbiol; 2017; 7():346. PubMed ID: 28824881
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of colistin alone and in various combinations for the treatment of experimental osteomyelitis due to carbapenemase-producing Klebsiella pneumoniae.
Crémieux AC; Dinh A; Nordmann P; Mouton W; Tattevin P; Ghout I; Jayol A; Aimer O; Gatin L; Verdier MC; Saleh-Mghir A; Laurent F
J Antimicrob Chemother; 2019 Sep; 74(9):2666-2675. PubMed ID: 31263884
[TBL] [Abstract][Full Text] [Related]
19. Ceftazidime/avibactam alone or in combination with aztreonam against colistin-resistant and carbapenemase-producing Klebsiella pneumoniae.
Jayol A; Nordmann P; Poirel L; Dubois V
J Antimicrob Chemother; 2018 Feb; 73(2):542-544. PubMed ID: 29165563
[No Abstract] [Full Text] [Related]
20. Antimicrobial activity of eugenol against carbapenem-resistant Klebsiella pneumoniae and its effect on biofilms.
Qian W; Sun Z; Wang T; Yang M; Liu M; Zhang J; Li Y
Microb Pathog; 2020 Feb; 139():103924. PubMed ID: 31837416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
